GNH USA

Europe — EMA

Paliperidona Pentafarma (Paliperidone)

Paliperidone, the active ingredient in Paliperidona Pentafarma, is an atypical antipsychotic presented as a unknown/unknown for oral use. It treats schizophrenia and schizoaffective disorder in adults.

Request sourcing

1
Pack/s

What is Paliperidone?

Paliperidone, the active ingredient in Paliperidona Pentafarma, is an atypical antipsychotic presented as a unknown/unknown for oral use. It treats schizophrenia and schizoaffective disorder in adults. GNH USA supplies Paliperidona Pentafarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Paliperidona Pentafarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Paliperidone used for?

Paliperidone acts on the dopamine and serotonin pathways for the treatment of serious psychiatric disorders.  - Schizophrenia: Provides symptom‑reduction and relapse‑prevent prevent prevent ... -   

What are the side effects of Paliperidone?

Common Side Effects: - …  - … ...

What precautions apply to Paliperidone?

Intro ...

What does Paliperidone interact with?

Major ....

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Paliperidone
Route
Oral Use
Manufacturer
Pentafarma - Sociedade Tecnico-Medicinal S.A.
Origin
EU

Related products